Quest Diagnostics Inc

Research Quest Diagnostics Inc (DGX) on Bullrun: valuation model: 6.5% undervalued, market cap USD 23.54B, P/E 23.5, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDGX
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Valuation signal6.5% undervalued
• Market capUSD 23.54B
• P/E23.5
• Dividend yield1.5%
• Financial periodFY2025
• RevenueUSD 11.04B
• Revenue growth11.8%
• Net incomeUSD 992.00M
• Free cash flowUSD 1.36B
• Gross margin33.2%

Valuation Snapshot

Bullrun's latest valuation model marks Quest Diagnostics Inc as 6.5% undervalued; latest market cap is USD 23.54B; P/E is 23.5; dividend yield is 1.5%.

About Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Frequently asked questions

Is Quest Diagnostics Inc overvalued or undervalued?

Bullrun's valuation model currently marks Quest Diagnostics Inc as 6.5% undervalued.

What is Quest Diagnostics Inc's market cap?

Quest Diagnostics Inc's market capitalization is USD 23.54B.

What is Quest Diagnostics Inc's P/E ratio?

Quest Diagnostics Inc's price-to-earnings (P/E) ratio is 23.5.

Does Quest Diagnostics Inc pay a dividend?

Quest Diagnostics Inc has a dividend yield of 1.5%.

What does Quest Diagnostics Inc do?

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.